Search results for: 'markets for injects as protein source'
- Related search terms
- Markets & Markets, Synthetic Biology – Global forecast to 2027, 2023. 01
- markets ad trends generator ® iot 2024
- markets ad trends generator ® imag 2014
- forces managed security services market study
- markets ad trends generator ® imag 2026
-
08 Sep 2025  |  Global  |  Market Research
Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030
Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery
The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...
$4,950.00 -
20 Feb 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...
$950.00 -
31 Jul 2026  |  Global  |  Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
Expansion in Sterile Fill-Finish and ADC-Payload-Linkers Capabilities Will Meet Critical Demand for High-Value Injectables
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...
$2,450.00 -
19 Jun 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...
$950.00 -
26 Nov 2025  |  Global  |  Market Research
Future of Bio-Pharma Industry, 2040
Adoption of Artificial Intelligence Is Driving Transformational Growth Across the Biopharma Value Chain
The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...
$2,450.00 -
05 Nov 2025  |  Global  |  Market Research
Global Pharmacovigilance and Safety Testing Outsourcing Services Market, Forecast to 2030
A Growing Focus on Precision Medicine and a Converging Ecosystem of Service Providers is Driving Market Growth
The global pharmaceutical industry strives to build an inclusive partner ecosystem that integrates technology, data, and regulatory standardization-enabled innovation into clinical trial delivery. This transformation aims to reduce the burden on investigators and sites while improving the efficiency and accuracy of adverse event (AE) tracking. Driv...
$4,950.00 -
16 Aug 2016  |  North America  |  Market Research
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
Emerging Business Models Drive Transformation
The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients (APIs) and intermediates; and finished dose formulations (FDFs), further segmented by solid, liquid and semi-solid, and injectable doses—and to understand the value chain from clinical to comme...
$7,000.00
Special Price $5,250.00 save 25 %
-
11 Jul 2025  |  Global  |  Market Outlook
Global Pharmaceutical Industry Outlook, 2025
Industry Convergence and Technology Adoption Lead to Transformational Growth
In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...
$4,950.00
Special Price $4,455.00 save 10 %
-
17 Jul 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Precision Diagnostics, Advanced Biologics, and Next-generation Vaccines
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...
$950.00 -
18 May 2026  |  Global  |  Frost Radar
Frost Radar™: Smart Delivery Formulations for Biologics, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Biologics, particularly peptide and protein therapies, are a rapidly growing therapeutic area because they can target complex biological pathways with high efficacy. These therapies are becoming important in oncology, metabolic disease, and autoimmune conditions supported by the growing global disease burden and growth in areas such as GLP-1s and m...
$4,950.00